Nuzenio

Neuroendocrine Carcinomas

Neuroendocrine Carcinomas news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

FDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 16:09:36 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSciAllSci · Tue, 04 Aug 2026 12:20:33 GMTFDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - onclive.comonclive.com · Mon, 03 Aug 2026 15:59:22 GMTU.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMTUrgent Chemotherapy for Aggressive Metastatic Neuroendocrine Cancer With Impending Hepatic Failure: A Case Report - CureusCureus · Wed, 29 Jul 2026 21:40:07 GMT

Timeline

Wed, 05 Aug 2026 16:09:36 GMTFDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas - Targeted Oncology
Tue, 04 Aug 2026 12:20:33 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSci
Mon, 03 Aug 2026 15:59:22 GMTFDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - onclive.com
Mon, 03 Aug 2026 11:00:00 GMTU.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) - Business Wire
Wed, 29 Jul 2026 21:40:07 GMTUrgent Chemotherapy for Aggressive Metastatic Neuroendocrine Cancer With Impending Hepatic Failure: A Case Report - Cureus

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Neuroendocrine Carcinomas.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.